 | • レポートコード：B-MOR-040827 • 出版社/出版日：Mordor Intelligence / 2018年2月 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：医療・バイオ |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、人工臓器の世界市場について調べ、人工臓器の世界規模、市場動向、市場環境、臓器タイプ別（心臓、腎臓、肝臓、すい臓、肺）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・人工臓器の世界市場インサイト ・人工臓器の世界市場環境 ・人工臓器の世界市場動向 ・人工臓器の世界市場規模 ・人工臓器の世界市場規模：臓器タイプ別（心臓、腎臓、肝臓、すい臓、肺） ・人工臓器の世界市場：地域別市場規模・分析 ・人工臓器の北米市場規模・予測 ・人工臓器のアメリカ市場規模・予測 ・人工臓器のヨーロッパ市場規模・予測 ・人工臓器のアジア市場規模・予測 ・人工臓器の日本市場規模・予測 ・人工臓器の中国市場規模・予測 ・人工臓器のインド市場規模・予測 ・人工臓器の韓国市場規模・予測 ・関連企業情報・競争状況 |
The global artificial organs market report covers artificial organs that are manmade applications integrated into the human body, to replace natural organs. Artificial organs replicate the functioning of natural organs and enable patients to return to a normal life, as soon as possible. The global artificial organ market is expected to register a CAGR of 9% during the forecast period of 2018-2023.
Scarcity of Donor Organs
The lack of availability of potential organs to transplant has been a major issue of concern. There is an ever-increasing demand for organ donors, and this demand is very high when compared to the actual supply. It has been estimated that, owing to the scarcity of donor organs, among all the patients who need organ transplantation, only 10% are able to undergo the process. In the United States, more than 119,000 patients are on the waiting list for organ transplantation. Around 22 patients die each year, due to the lack of available organs for transplantation. In Europe, by the end of 2015, more than 143,000 patients were waiting for an organ transplantation. In this region, 18 patients die each year, due to lack of available organs for transplantation.
The increased incidence of disabilities and organ failures, technological advancements in the artificial organs sector, and rapidly aging population are some other drivers of the market.
Expensive Procedures
Cost of the procedure is a major constraint for the artificial organ market. The high cost of these organs can be attributed to the production policies required to address the patients, taxpayers, and medical technology corporations. For instance, organ transplantation has several issues in the current market scenario, such as the policies for procurement, transplant tourism, organ trafficking, and others.
Additionally, fear of device malfunction and its consequences are also restraining the market’s growth.
North America to Dominate the Market
The global artificial organ market has been segmented by organ type and geography. By organ type, the market has been segmented into artificial heart, artificial kidney, artificial livers, artificial pancreas, and artificial lungs. By geography, it has been segmented into North America, Europe, Asia-Pacific, Middle East & Africa, and South America.
Due to increased incidences of organ failures, disabilities, and scarcity in the availability of donor organs, recent technological advancements, and the rapid rise of the geriatric population, North America dominates the market.
Major Players- EDWARD LIFESCIENCES CORPORATION, ASAHI KASEI MEDICAL CO. LTD, JARVIK HEART INC., BOSTON SCIENTIFIC CORPORATION, COCHLEAR LIMITED, TOUCH BIONICS, OSSUR, MEDTRONIC INC., LIFENET HEALTH, amongst others.
Reasons to Purchase this Report
• Analysis of the global artificial organ market, with region-specific assessments and competition analysis on global and regional scales
• Analyzing various perspectives of the industry with the help of Porter’s five forces analysis
• The treatment type that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support along with the Market Estimate sheet (in excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Market Overview
5.3 Porter’s Five Force Analysis
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Degree of Competition
5.3.4 Threat of Substitution
5.3.5 Threat of New Entrants
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Scarcity of Donor Organs
6.1.2 Increased Incidence of Disabilities and Organ Failures
6.1.3 Technological Advancements in the Artificial Organ Sector
6.1.4 Rapidly Aging Population
6.2 Market Restraints
6.2.1 Expensive Procedures
6.2.2 Fear of Device Malfunction and its Consequences
6.3 Opportunities
6.3.1 Emerging Application in Clinical Diagnostics and Proteomics
6.4 Challenges
7. Market Segmentation
7.1 By Organ Type
7.1.1 Artificial Heart
7.1.1.1 Prosthetic Heart Valves
7.1.1.2 Ventricular Assist Devices
7.1.2 Artificial Kidney
7.1.2.1 Dialysis
7.1.3 Artificial Livers
7.1.3.1 Liver Dialysis
7.1.3.2 Bio artificial Liver Device (BAL)
7.1.3.3 Molecular Adsorbent Recirculation Systems (MARS)
7.1.3.4 Single Pass Albumin Dialysis (SPAD)
7.1.3.5 Prometheus
7.1.4 Artificial Pancreas
7.1.4.1 Insulin Pump
7.1.5 Artificial Lungs
7.1.5.1 Extracorporeal Membrane Oxygenation
7.1.5.2 Heart-Lung Machines
7.2 By Geography
7.2.1 North America
7.2.1.1 US
7.2.1.2 Canada
7.2.1.3 Mexico
7.2.2 Europe
7.2.2.1 Germany
7.2.2.2 UK
7.2.2.3 France
7.2.2.4 Italy
7.2.2.5 Spain
7.2.2.6 Rest of Europe (RoE)
7.2.3 Asia Pacific
7.2.3.1 Japan
7.2.3.2 China
7.2.3.3 India
7.2.3.4 South Korea
7.2.3.5 Australia
7.2.3.6 Rest of Asia Pacific
7.2.4 The Middle East & Africa
7.2.4.1 GCC Countries
7.2.4.2 South Africa
7.2.4.3 Rest of Middle East & Africa
7.2.5 South America
7.2.5.1 Brazil
7.2.5.2 Argentina
7.2.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisitions
8.2 Agreements, Collaborations & Partnerships
8.3 New Product Launches
9. Key Players
9.1 Edward Life sciences Corporation
9.2 Asahi Kasei Medical Co. Ltd
9.3 Jarvik Heart Inc.
9.4 Boston Scientific Corporation
9.5 Cochlear Limited
9.6 Touch Bionics
9.7 Ossur
9.8 Medtronic Inc.
9.9 Lifenet Health
10. Future of the Market